Investigations on the formation of urinary coproporphyrin isomers I-IV in 5-aminolevulinic acid dehydratase deficiency porphyria, acute lead intoxication and after oral 5-aminolevulinic acid loading

Clinical Biochemistry

Volumn 32, Issue 2, 1999, Pages 119-123

  Jacob, Karl ^a   Egeler, Emil ^a   Groß, Ulrich ^b   Doss, Manfred O ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

5 aminolevulinic acid; 5 aminolevulinic acid dehydratase deficiency porphyria; Acute lead intoxication; Atypical coproporphyrin isomers; Coproporphyrin isomers; Coproporphyrinogens; Oral 5 aminolevulinic acid loading; Urinary coproporphyrins

Indexed keywords

AMINOLEVULINIC ACID; COPROPORPHYRIN; PORPHOBILINOGEN SYNTHASE;

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; CHEMICAL COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SIMULATION; HUMAN; ISOMERISM; LEAD POISONING; LOADING TEST; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REACTION ANALYSIS; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADMINISTRATION, ORAL; AMINOLEVULINIC ACID; COPROPORPHYRINS; HUMANS; ISOMERISM; LEAD POISONING; MALE; PORPHOBILINOGEN SYNTHASE; PORPHYRIA, ACUTE INTERMITTENT;

EID: 0033032226     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00104-0     Document Type: Article

References (23)

1. Doss M., von Tiepermann R., Schneider J., Schmid H. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr. 57:1979;1123-1127.
2. Kappas A., Sassa S., Galbraith R.A., Nordmann Y. The porphyrias. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic and molecular bases of inherited disease. 1995;2103-2159 McGraw-Hill Book Company, New York.
3. Doss M., von Tiepermann R., Schneider J. Acute hepatic porphyria syndrome with porphobilinogen synthase defect. Int J Biochem. 12:1980;823-826.
4. Campbell B.C., Brodie M.J., Thompson G.G., et al. Alterations in the activity of enzymes of haem biosynthesis in lead poisoning and acute hepatic porphyria. Clin Sci Mol Med. 53:1977;335-340.
5. Moore M.R., McColl K.E.L., Rimington C., Goldberg A. Disorders of porphyrin metabolism. 1987;Plenum Publishing Corporation, New York, London.
6. Meyer U.A., Strand L.J., Doss M., Rees C., Marver H.S. Intermittent acute porphyria - demonstration of a genetic defect in porphobilinogen metabolism. N Engl J Med. 286:1972;1277-1282.
7. Doss M. Metabolism of δ-aminolaevulinic acid and porphobilinogen in human erythrocytes in acute intermittent porphyria. Enzyme. 16:1973;343-353.
8. Mustajoki P., Tenhunen R. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity. Eur J Clin Invest. 15:1985;281-284.
9. Doss M.O. Porphyrinurias and occupational disease. New York Acad Sci. 514:1987;204-218.
10. Peng Q., Berg K., Moan J., Kongshaug M., Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy principles and experimental research . Photochem Photobiol. 65:1997;235-251.
11. Regula J., MacRobert A.J., Gorchein A., et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5-aminolaevulinic acid induced protoporphyrin IX - a pilot study. Gut. 36:1995;67-75.
12. Webber J., Kessel D., Fromm D. Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid. J Photochem Photobiol B: Biol. 37:1997;151-153.
13. Rick K., Sroka R., Stepp H., et al. Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B: Biol. 40:1997;313-319.
14. Doss M., Schermuly E. Urinary porphyrin excretion pattern and isomer distribution of I and III in human porphyrin disorders. Doss M. Porphyrins in human diseases. 1976;189-204 Karger, Basel.
15. Jacob K., Egeler E., Hennel B., Luppa P. Coproporphyrin isomers II and IV are normal constituents of human urine. J Clin Chem Clin Biochem. 27:1989;659-661.
16. Jacob K., Egeler E., Hennel B., Neumeier D., Luppa P. Application of ion-pair high-performance liquid chromatography to detection of the atypical coproporphyrin isomers II and IV in human faeces. J Chromatogr. 572:1991;317-320.
17. Jacob K., Doss M.O. Composition of urinary coproporphyrin isomers I-IV in human porphyrias. Eur J Clin Chem Clin Biochem. 31:1993;617-624.
18. Jacob K., Doss M.O. Excretion pattern of faecal coproporphyrin isomers I-IV in human porphyrias. Eur J Clin Chem Clin Biochem. 33:1995;893-901.
19. Jacob K., Luppa P. Application of ion pair high performance liquid chromatography to the analysis of porphyrins in clinical samples. Biomed Chromatogr. 5:1991;122-127.
20. Mauzerall D. The thermodynamic stability of porphyrinogens. J Am Chem Soc. 82:1960;2601-2605.
21. Mathewson J.H., Corwin A.H. Biosynthesis of pyrrole pigments a mechanism for porphobilinogen polymerization . J Amer Chem Soc. 83:1961;135-137.
22. Stark W.M., Hart G.J., Battersby A.R. Synthetic studies on the proposed spiro intermediate for biosynthesis of the natural porphyrins inhibition of cosynthetase . J Chem Soc Chem Commun. 1986;465-467.
23. von Dobeneck H., Hansen B., Vollmann E. The probabilities of the isomerization of uroporphyrinogens in hot acid. Z Naturforsch. 27B:1972;922-924.